When:
October 27, 2021 @ 5:57 pm – October 27, 2022 @ 6:57 pm
2021-10-27T17:57:00-04:00
2022-10-27T18:57:00-04:00


Grand Rounds Specialty Series Enduring – Severe Asthma: Reducing Disease Burden with Step-up Therapy

View Activity

PROGRAM CHAIR

Nicola A. Hanania, MD, MS, FRCP(C), FCCP, FACP, FERS, ATSF (PROGRAM CHAIR)
Director, Airway Clinical Research Center
Interim Chief, Pulmonary and Critical Care Medicine
Ben Taub Hospital, Baylor College of Medicine
Houston, TX

SPEAKING FACULTY

Michael Wechsler, MD
Professor of Medicine – National Jewish Health
Director, National Jewish Cohen Family Asthma Institute
Denver, CO

PROGRAM OVERVIEW

The case-based online activity will cover the treatment and management of patients with severe asthma.

TARGET AUDIENCE

This CME activity is designed to meet the educational needs of pulmonologists, allergists, primary care physicians, pediatricians, and other health care providers involved in the management of patients with severe uncontrolled asthma.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Assess disease severity and intensify therapy as needed to manage the symptoms and quality-of-life issues associated with uncontrolled severe asthma in pediatric and adult patients
  • Utilize biomarkers and asthma phenotypes to personalize the selection of treatment options for pediatric and adult patients with severe asthma
  • Incorporate current treatment recommendations and clinical trial data for the management of severe asthma into clinical practice

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group will designate each online activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with severe asthma.
CNE Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT: Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Nicola A. Hanania, MD Discloses that he has received Consulting fees from GSK, Boehringer Ingelheim, Novartis, AstraZeneca, Sanofi, Teva and Amgen. He also has worked on the Speakers Bureau for AstraZeneca and Sanofi, and has received funds for contracted research from GSK, Boehringer Ingelheim, Novartis, Genentech, AstraZeneca, Sanofi and Teva

Michael Wechsler, MD Discloses that he has received consulting fees from AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron, Novartis, Genentech, Teva, Boehringer Ingelheim, Equillium and Amgen

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CME Content Review
The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose

Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Michael Page, PharmD, RPh, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

RELEASE DATE: October 27, 2021

EXPIRATION DATE: October 27, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity